Skip to main content
. Author manuscript; available in PMC: 2019 Dec 22.
Published in final edited form as: Vaccine. 2019 May 30;37(28):3730–3734. doi: 10.1016/j.vaccine.2019.04.088

Table 1.

Characteristics of recipients of excess doses of vaccine reported to VAERS, January 2007—July 2017.

Characteristic
Median age (range), years 11(0–98)
No (%)
Number of reports 5067
Serious 158 (3.1)
Reports with no adverse health event 3898 (76.9)
Female sex 1849 (36.5)
Male sex 1426 (28.1)
Unknown sex 1792 (35.4)
Age groupsa
0–11 months 438 (8.6)
1–6 years 1089 (21.5)
7–18 years 731 (14.4)
19–64 years 808 (16.0)
≥65 years 379 (7.5)
Type of reporter
Manufacturer 3168 (62.5)
Provider 1180 (23.3)
Other 619 (12.2)
Parent/patient 100 (2.0)
a

Age unknown in 1622 (32%).